Hyundai Bioscience Revenue

Hyundai Bioscience had revenue of 708.79M KRW in the quarter ending March 31, 2025, a decrease of -85.96%. This brings the company's revenue in the last twelve months to 10.71B, down -5.80% year-over-year. In the year 2024, Hyundai Bioscience had annual revenue of 15.05B with 58.73% growth.

Revenue (ttm)

10.71B

Revenue Growth

-5.80%

P/S Ratio

65.11

Revenue / Employee

198.32M

Employees

Market Cap

697.24B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	15.05B	5.57B	58.73%
Dec 31, 2023	9.48B	1.63B	20.76%
Dec 31, 2022	7.85B	-1.39B	-15.04%
Dec 31, 2021	9.24B	-3.27B	-26.14%
Dec 31, 2020	12.51B	-17.57B	-58.41%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,898.69B
Celltrion	3,662.23B
ALTEOGEN	151.65B
Yuhan	2,114.76B
SK Biopharmaceuticals	578.00B
HLB Co., Ltd.	74.64B
Peptron	4.30B
PharmaResearch	392.31B

Revenue Rankings